In silico approach to cisplatin toxicity. Quantum chemical studies on platinum(II) - Cysteine systems

Journal of Molecular Modeling

Volumn 15, Issue 6, 2009, Pages 659-664

  Chojnacki, Henryk ^a   Kuduk Jaworska, Janina ^b   Jaroszewicz, Iwona ^b   Jański, Jerzy J ^b  

^a WROCLAW UNIVERSITY OF TECHNOLOGY   (Poland)

^b UNIVERSITY OF WROC AW   (Poland)

Author keywords

Cisplatin; Interactions with deprotonated thiomethanol and cysteine; Transplatin

Indexed keywords

CISPLATIN; CYSTEINE; DEPROTONATED THIOMETHANOL; PLATINUM COMPLEX; THIOL DERIVATIVE; TRANSPLATIN; UNCLASSIFIED DRUG;

COMPUTER MODEL; CONFERENCE PAPER; DENSITY FUNCTIONAL THEORY; ELECTROSTATIC POTENTIAL; ENERGY; MOLECULAR INTERACTION; MOLECULAR INTERACTION ENERGY; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; QUANTUM CHEMISTRY; REACTION ANALYSIS;

ANTINEOPLASTIC AGENTS; CISPLATIN; COMPUTER SIMULATION; CYSTEINE; HUMANS; MODELS, CHEMICAL; MODELS, MOLECULAR; PLATINUM; QUANTUM THEORY; SULFIDES;

EID: 67349212894     PISSN: 16102940     EISSN: 09485023     Source Type: Journal    
DOI: 10.1007/s00894-009-0469-2     Document Type: Conference Paper

References (39)

1. Rosenberg B (1973) Naturwissenschaften 60:399-406
2. O'Dwyer PJ, Stevenson JP (1999) In: Lippert B (ed) Cisplatin. Chemistry and biochemistry of a leading anticancer drug. Wiley-VCH, Weinheim, pp 31-72
3. Reedijk J, Teuben JM (1999) In: Lippert B (ed) Cisplatin. Chemistry and biochemistry of a leading anticancer Drug. Wiley-VCH, Weinheim, pp 339-362
4. Hannemann J, Baumann K (1990) Arch Toxicol 64:393-400
5. Gelasco A, Lippard SJ (1999) Top Biol Inorg Chem 1:1-43
6. Lempers ELM, Reedijk J (1991) Adv Inorg Chem 37:175-217
7. Berners-Price SJ, Kuchel PW (1990) J Inorg Biochem 38:305-326
8. Holler E (1993) In: Keppler BK (ed) Metal complexes in cancer chemotherapy. VCH, Weinheim, pp 37-71
9. Corden BJ (1987) Inorg Chim Acta 137:125-130
10. Hambley TW (1997) Coord Chem Rev 166:181-223
11. Fichtinger-Schepman AMJ, Van der Veer JL, den Hartog JHJ, Lohman PHM, Reedijk J (1985) Biochemistry 24:707-713
12. Wang K, Lu J, Li R (1996) Coord Chem Rev 151:53-88
13. Hanigan MH, Devarajan P (2003) Cancer Ther 1:47-61
14. Wang X, Guo Z (2007) Anticancer Agents Med Chem 7:19-34
15. Heudi O, Cailleux A, Allain PJ (1998) Inorg Biochem 71:61-69
16. Bose RN, Moghaddes S, Weaver EL, Cox EH (1995) Inorg Chem 34:5878-5883
17. Wang D, Lippard SJ (2005) Nat Rev Drug Discov 4:307-320
18. Daley-Yates PT, McBrien DCA (1982) Chem-Biol Interact 40:325-334
19. Sugiyama S, Hayakawa M, Kato T, Hanaki Y, Shimizu K, Ozawa T (1989) Biochem Biophys Res Commun 159:1121-1127
20. Zhang JG, Lindup WE (1994) Biochem Pharmacol 47:1127-1135
21. Xin Yao, Panichpisal K, Kurtzman N, Nugent K (2007) Cisplatin nephrotoxicity: A review. Am J Med Sci 334:115-124
22. Bancroft DP, Lepre CA, Lippard SJ (1990) J Am Chem Soc 112:6860-6871
23. Lepre CL, Lippard SJ (1990) In: Eckstein F, Lilley DMJ (eds) Nucleic acids and molecular biology, vol 4. Springer, Berlin, pp 9-38
24. Bloemink MJ, Reedijk J (1996) Metal Ions Biol Sys 32:641-685
25. Wong E, Giandomenico CM (1999) Chem Rev 99:2451-2466
26. Reedijk J, Lempers ELM (1991) Adv Inorg Chem 37:175-217
27. Brabec V, Kasparkova J Drug Resistance Updates (2002) 5:147-161
28. Zimmermann T, Zeizinger M, Burda JV (2005) J Inorg Biochem 99:2184-2196
29. Lau JK-C, Deubel DV (2005) Chem Eur J 11:2849-2855
30. Deubel DV (2002) J Am Chem Soc 124:5834-5842
31. Deubel DV (2004) J Am Chem Soc 126:5999-6004
32. Cleare MJ, Hoeschele JD (1973) Bioinorg Chem 2:187-210
33. Dedon PC, Borch RF (1987) Biochem Pharmacol 36:1955-1964
34. Huzinaga S (1984) Gaussian basis sets for molecular calculations. Elsevier, Amsterdam
35. WTBS Basis Set: http://bse.pn.gov/bse.portal
36. http://OpenMOPAC.net
37. GAUSSIAN-03, (2003) Rev. D-01 Gaussian Inc., Pittsburgh PA 2003
38. MOLEKEL-5.3: http://www.cscs.ch/index.php?
39. Burda JV, Gu J (2008) J Inorg Biochem 102:53-62